Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro
- PMID: 17143303
- PMCID: PMC2042901
- DOI: 10.1038/sj.bjp.0706971
Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro
Abstract
Background and purpose: Two compounds, URB602 and URB754, have been reported in the literature to be selective inhibitors of monoacylglycerol lipase, although a recent study has questioned their ability to prevent 2-arachidonoyl hydrolysis by brain homogenates and cerebellar membranes. In the present study, the ability of these compounds to inhibit monoacylglycerol lipase and fatty acid amide hydrolase has been reinvestigated.
Experimental approach: Homogenates and cell lines were incubated with test compounds and, thereafter, with either [(3)H]-2-oleoylglycerol or [(3)H]-anandamide. Labelled reaction products were separated from substrate using chloroform: methanol extraction.
Key results: In cytosolic fractions from rat brain, URB602 and URB754 inhibited the hydrolysis of 2-oleoylglycerol with IC(50) values of 25 and 48 microM, respectively. Anandamide hydrolysis by brain membranes was not sensitive to URB754, but was inhibited by URB602 (IC(50) value 17 microM). Hydrolysis of 2-oleoylglycerol by human recombinant monoacylglycerol lipase was sensitive to URB602, but not URB754. The lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis was also observed for intact RBL2H3 basophilic leukaemia cells. C6 glioma expressed mRNA for monoacylglycerol lipase, and hydrolyzed 2-oleoylglycerol in a manner sensitive to inhibition by methyl arachidonoyl fluorophosphonate but not URB754 or URB597. MC3T3-E1 mouse osteoblastic cells, which did not express mRNA for monoacylglycerol lipase, hydrolyzed 2-oleoylglycerol in the presence of URB597, but the hydrolysis was less sensitive to methyl arachidonoyl fluorophosphonate than for C6 cells.
Conclusions and implications: The data demonstrate that the compounds URB602 and URB754 do not behave as selective and/or potent inhibitors of monoacylglycerol lipase.
Figures

Similar articles
-
Chemical probes of endocannabinoid metabolism.Pharmacol Rev. 2013 Mar 19;65(2):849-71. doi: 10.1124/pr.112.006387. Print 2013 Apr. Pharmacol Rev. 2013. PMID: 23512546 Free PMC article. Review.
-
Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase.J Med Chem. 2007 Oct 4;50(20):5012-23. doi: 10.1021/jm070642y. Epub 2007 Sep 1. J Med Chem. 2007. PMID: 17764163
-
Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.Br J Pharmacol. 2005 Aug;145(7):885-93. doi: 10.1038/sj.bjp.0706253. Br J Pharmacol. 2005. PMID: 15895107 Free PMC article.
-
URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices.Chem Biol. 2007 Dec;14(12):1357-65. doi: 10.1016/j.chembiol.2007.10.017. Chem Biol. 2007. PMID: 18096504 Free PMC article.
-
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.Proc Nutr Soc. 2014 Feb;73(1):96-105. doi: 10.1017/S0029665113003649. Epub 2013 Oct 18. Proc Nutr Soc. 2014. PMID: 24135210 Review.
Cited by
-
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model.Life Sci. 2013 Mar 19;92(8-9):498-505. doi: 10.1016/j.lfs.2012.06.020. Epub 2012 Jun 28. Life Sci. 2013. PMID: 22749865 Free PMC article.
-
Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.Pharmacol Biochem Behav. 2011 Mar;98(1):21-7. doi: 10.1016/j.pbb.2010.12.002. Epub 2010 Dec 8. Pharmacol Biochem Behav. 2011. PMID: 21145341 Free PMC article.
-
Chemical probes of endocannabinoid metabolism.Pharmacol Rev. 2013 Mar 19;65(2):849-71. doi: 10.1124/pr.112.006387. Print 2013 Apr. Pharmacol Rev. 2013. PMID: 23512546 Free PMC article. Review.
-
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.Exp Neurol. 2015 Nov;273:36-44. doi: 10.1016/j.expneurol.2015.07.024. Epub 2015 Aug 2. Exp Neurol. 2015. PMID: 26244281 Free PMC article.
-
Microglia produce and hydrolyze palmitoylethanolamide.Neuropharmacology. 2008 Jan;54(1):16-22. doi: 10.1016/j.neuropharm.2007.05.015. Epub 2007 Jun 2. Neuropharmacology. 2008. PMID: 17631917 Free PMC article.
References
-
- Boldrup L, Wilson SJ, Barbier AJ, Fowler CJ. A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase. J Biochem Biophys Meth. 2004;60:171–177. - PubMed
-
- Brengdahl J, Fowler CJ. A novel assay for monoacylglycerol hydrolysis suitable for high-throughput screening. Anal Biochem. 2006;359:40–44. - PubMed
-
- Dinh TP, Kathuria S, Piomelli D. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol Pharmacol. 2004;66:1260–1264. - PubMed
-
- Goparaju SK, Ueda N, Yamaguchi H, Yamamoto S. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett. 1998;422:69–73. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources